Form 4: uniQure CEO Matthew Kapusta Reports Share Transactions

uniQure CEO Matthew Kapusta reports acquisition and disposal of ordinary shares and stock options.

Summary

• On March 3, 2025, Matthew Kapusta, CEO and Managing Director of uniQure N.V., acquired 99,000 ordinary shares through restricted share units and was granted stock options for 171,000 shares.
• On March 4, 2025, Kapusta disposed of 28,341 ordinary shares at a weighted average price of $10.29 per share to cover estimated withholding taxes upon vesting of restricted share units.
• Following these transactions, Kapusta beneficially owns 651,454 ordinary shares and 171,000 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document primarily reports routine transactions related to executive compensation. There are no indications of significant positive or negative developments.

Positives

• The grant of restricted share units and stock options to the CEO aligns his interests with those of the shareholders.
• The vesting schedule of the restricted share units and stock options incentivizes continued service with the company.

Negatives

• The sale of shares to cover withholding taxes, while routine, slightly reduces the CEO's direct shareholding.

Risks

• Future sales of shares by the CEO could potentially exert downward pressure on the stock price.

Industry Context

Share transactions by company executives are routinely monitored by investors as they can provide insights into management's confidence in the company's prospects. This filing is a standard disclosure and doesn't necessarily indicate a change in the company's outlook.

Comparison to Industry Standards

• Executive compensation packages including stock options and restricted share units are common in the biotechnology industry to incentivize performance and align management interests with shareholders.
• The vesting schedules described are typical for such grants, encouraging long-term commitment from the executive.
• Sales of shares to cover tax obligations are also a standard practice among executives receiving equity compensation.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they involve the CEO's personal holdings and tax obligations.
• Employees may view the equity grants as a positive sign of the company's commitment to its leadership.

Key Dates